子痫前期外部验证预测模型的系统综述与Meta分析
该系统综述与Meta分析评估了现有外部验证的子痫前期预测模型(任何型、早发型、晚发型和早产型)的性能,共纳入23项研究、52个模型。早产型子痫前期的Fetal Medicine Foundation(FMF)竞争风险模型(三联检测加母体因素)表现最佳,汇总AUC为0.90(95%预测区间0.76-0.96),且校准良好;其他模型判别性能一般至良好(中位AUC 0.66,范围0.53-0.77),并在外部验证中过拟合。
要点
- 早产型子痫前期FMF三联检测模型汇总AUC 0.90(95%PI 0.76-0.96),校准良好。
- 其他模型判别性能中位AUC 0.66(范围0.53-0.77),外部验证中过拟合。
- 常用预测因子为母体特征(孕前BMI、既往PE、家族史、慢性病、 ethnicity)和生物标志物(子宫动脉搏动指数、PAPP-A)。
核心结论
- 现有外部验证的任何型、早发型和晚发型子痫前期预测模型判别和校准性能有限,输入变量不一致;三联检测FMF模型在多个场景中对早产型子痫前期预测具有出色判别性能,但特殊生物标志物的纳入可能限制其在高资源环境外的可行性和实施。
研究设计与样本
- 系统综述与Meta分析,检索五个数据库(MEDLINE、EMBASE、Emcare、CINAHL和Maternity & Infant Care Database)及Google Scholar/参考文献,截至2023年5月20日,基于PICOTS框架,使用CHARMS清单提取数据,PROBAST工具评估偏倚风险,共纳入23项研究、52个外部验证预测模型。
诊断标准与关键数值
- 早产型子痫前期FMF模型(三联检测加母体因素)汇总AUC 0.90(95%PI 0.76-0.96),校准良好。
- 其他模型判别性能中位AUC 0.66(范围0.53-0.77)。
- 任何型子痫前期中仅两个基于母体特征的多次验证模型汇总AUC分别为0.71(95%PI 0.66-0.76)和0.73(95%PI 0.55-0.86)。
临床应用与阅片要点
- 早产型子痫前期预测可参考FMF三联检测模型,其汇总AUC为0.90且校准良好,但特殊生物标志物可能限制高资源环境外的可行性;其他模型判别性能有限且外部验证中过拟合。
局限性
- 现有外部验证的任何型、早发型和晚发型子痫前期预测模型判别和校准性能有限,且输入变量不一致。
- 除FMF模型外,其他模型在外部验证中过拟合。
- 三联检测FMF模型纳入特殊生物标志物,可能限制其在高资源环境外的可行性和实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This systematic review and meta-analysis aimed to evaluate the performance of existing externally validated prediction models for pre-eclampsia (PE) (specifically, any-onset, early-onset, late-onset and preterm PE).
METHODS: A systematic search was conducted in five databases (MEDLINE, EMBASE, Emcare, CINAHL and Maternity & Infant Care Database) and using Google Scholar/reference search to identify studies based on the Population, Index prediction model, Comparator, Outcome, Timing and Setting (PICOTS) approach until 20 May 2023. We extracted data using the CHARMS checklist and appraised the risk of bias using the PROBAST tool. A meta-analysis of discrimination and calibration performance was conducted when appropriate.
RESULTS: Twenty-three studies reported 52 externally validated prediction models for PE (one preterm, 20 any-onset, 17 early-onset and 14 late-onset PE models). No model had the same set of predictors. Fifteen any-onset PE models were validated externally once, two were validated twice and three were validated three times, while the Fetal Medicine Foundation (FMF) competing-risks model for preterm PE prediction was validated widely in 16 different settings. The most common predictors were maternal characteristics (prepregnancy body mass index, prior PE, family history of PE, chronic medical conditions and ethnicity) and biomarkers (uterine artery pulsatility index and pregnancy-associated plasma protein-A). The FMF model for preterm PE (triple test plus maternal factors) had the best performance, with a pooled area under the receiver-operating-characteristics curve (AUC) of 0.90 (95% prediction interval (PI), 0.76-0.96), and was well calibrated. The other models generally had poor-to-good discrimination performance (median AUC, 0.66 (range, 0.53-0.77)) and were overfitted on external validation. Apart from the FMF model, only two models that were validated multiple times for any-onset PE prediction, which were based on maternal characteristics only, produced reasonable pooled AUCs of 0.71 (95% PI, 0.66-0.76) and 0.73 (95% PI, 0.55-0.86).
CONCLUSIONS: Existing externally validated prediction models for any-, early- and late-onset PE have limited discrimination and calibration performance, and include inconsistent input variables. The triple-test FMF model had outstanding discrimination performance in predicting preterm PE in numerous settings, but the inclusion of specialized biomarkers may limit feasibility and implementation outside of high-resource settings. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Tiruneh SA, Vu CT, Moran LJ, et al. Externally validated prediction models for pre-eclampsia: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2024. PMID: 37724649. doi:10.1002/uog.27490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。